Photorefraction Screening Plus Atropine Treatment for Myopia is Cost-Effective: A Proof-of-Concept Markov Analysis

Chuen Yen Hong,1 Matt Boyd,2 Graham Wilson,3 Sheng Chiong Hong4 1Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; 2Adapt Research Ltd, Reefton, New Zealand; 3Matai Medical Research Institute, Gisborne, New Zealand; 4oDocs Eye Care, Dunedin, New ZealandCorrespondence: Chuen Yen...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hong CY, Boyd M, Wilson G, Hong SC
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2022-06-01
Edice:	Clinical Ophthalmology
Témata:	cost-benefit analysis photorefractive screening myopia atropine
On-line přístup:	https://www.dovepress.com/photorefraction-screening-plus-atropine-treatment-for-myopia-is-cost-e-peer-reviewed-fulltext-article-OPTH
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!